The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Self-citationRole for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90228-3 · Cited by 1,691
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Genetic progression model for head and neck cancer: implications for field cancerization.
Califano, J. A., van der Riet, P., Westra, W. H., Nawroz, H., Clayman, G. L., Piantadosi, S., Corio, R. L., Lee, D. J., Greenberg, B. M., Koch, W. M., et al. (1996) · PubMed · Cited by 1,355
Self-citationHerman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Self-citationThe Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,220
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Dickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008 · cited 2×
“Clearly, in the senescent state, pRb is in its hypophosphorylated form and levels of p16 RNA and protein are elevated [98, 97].”
BackgroundGermline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
The essentials of DNA methylation
Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90526-i · Cited by 948
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · cited 1×
“Additional support for this contention comes from the identification of mutations in cdk4 that inhibit p16 binding in 3 melanoma-prone families [55, 61, 62].”
BackgroundDiehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746
Role of the p16 tumor suppressor gene in cancer.
Liggett, W. H., & Sidransky, D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1197 · Cited by 746
Self-citationRegulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Gonzalez‐Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T. T., Beart, R. W., Tornout, J. M. V., & Jones, P. A. (1995) · PubMed · Cited by 695
Matrix metalloproteinases in tumour invasion and metastasis
Curran, S., & Murray, G. I. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199911)189:3<358::aid-path452>3.0.co;2-1 · Cited by 661
Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.
Schutte, M. E. M., Hruban, R. H., Geradts, J., Maynard, R. D., Hilgers, W., Rabindran, S. K., Moskaluk, C. A., Hahn, S. A., Schwarte‐Waldhoff, I., Schmiegel, W., et al. (1997) · PubMed · Cited by 659
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-210 · Cited by 627
Self-citationIncreased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4Mutations
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 622
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
Reed, A. L., Califano, J. A., Cairns, P., Westra, W. H., Jones, R. M., Koch, W. M., Ahrendt, S. A., Eby, Y. J., Sewell, D. A., Nawroz, H., et al. (1996) · PubMed · Cited by 575
Self-citationGene promoter hypermethylation in tumors and serum of head and neck cancer patients.
Sánchez‐Céspedes, M., Esteller, M., Wu, L. J., Nawroz-Danish, H., Yoo, G., Koch, W. M., Jen, J., Herman, J. G., & Sidransky, D. (2000) · PubMed · Cited by 540
Self-citationMutations and altered expression of p16INK4 in human cancer.
Okamoto, A., Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W. P., Forrester, K., Gerwin, B., Serrano, M., & Beach, D. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11045 · Cited by 539
The INK4A/ARF locus and its two gene products.
Sharpless, N. E., & DePinho, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80004-5 · Cited by 533 · cited 4×
“In a recent reanalysis of 714 primary tumors and cell lines in which the status of p14, p16, and p53 could be reasonably inferred, the authors concluded that the role for p14 in human malignancy appeared to be minor [91].”
BackgroundResultInfluentialAberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota, M., Ahuja, N., Suzuki, H., Itoh, F., Ohe-Toyota, M., Imai, K., Baylin, S. B., & Issa, J. J. (1999) · PubMed · Cited by 530
Russo, A. A., Tong, L., Lee, J.-O., Jeffrey, P. D., & Pavletich, N. P. (1998) · Nature · doi:10.1038/26155 · Cited by 524
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., & Dryja, T. P. (1991) · PubMed · Cited by 466
Growth suppression by p16ink4 requires functional retinoblastoma protein
Medema, R. H., Herrera, R. E., Lam, F., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6289 · Cited by 433
Rates of p16 ( MTS1 ) Mutations in Primary Tumors with 9p Loss
Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., & Sidransky, D. (1994) · Science · doi:10.1126/science.8023167 · Cited by 427
Self-citationDrexler, H. (1998) · Leukemia · doi:10.1038/sj.leu.2401043 · Cited by 426
Deletion of p16 and p15 genes in brain tumors.
Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S. D., Willson, J. K. V., Kinzler, K. W., & Vogelstein, B. (1994) · PubMed · Cited by 404
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Complex structure and regulation of the P16 (MTS1) locus.
Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H. L., Parry, D., Peters, G., & Kamb, A. (1995) · PubMed · Cited by 383
Zhang, H. S., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)80714-x · Cited by 349
Vasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Borg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., & Ingvar, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1260 · Cited by 345
Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Shapiro, G. I., Edwards, C. D., Kobzik, L., Godleski, J. J., Richards, W. G., Sugarbaker, D. J., & Rollins, B. J. (1995) · PubMed · Cited by 340
Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S., & Nakamura, Y. (1994) · PubMed · Cited by 333
Mao, L., Merlo, A. U., Bedi, G. C., Shapiro, G. I., Edwards, C. D., Rollins, B. J., & Sidransky, D. (1995) · PubMed · Cited by 329
Self-citationp16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
Cheng, J. Q., Jhanwar, S., Klein, W. M., Bell, D. W., Lee, W.-C., Altomare, D. A., Nobori, T., Olopade, O. I., Buckler, A., & Testa, J. R. (1994) · PubMed · Cited by 319
P16 gene in uncultured tumours
Spruck, C. H., Gonzalez-Zulueta, M., Shibata, A., Simoneau, A. R., Lin, M.-F., Gonzales, F., Tsai, Y. C., & Jones, P. A. (1994) · Nature · doi:10.1038/370183a0 · Cited by 318
McConnell, B. B., Starborg, M., Brookes, S., & Peters, G. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70137-x · Cited by 314
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)98734-r · Cited by 312
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
Gruis, N. A., van der Velden, P. A., Sandkuijl, L. A., Prins, D. E., Weaver-Feldhaus, J., Kamb, A., Bergman, W., & Frants, R. R. (1995) · Nature Genetics · doi:10.1038/ng0795-351 · Cited by 310
Pinyol, M., Cobo, F., Bea, S., Jares, P., Nayach, I., Fernandez, P. L., Montserrat, E., Cardesa, A., & Campo, E. (1998) · Blood · doi:10.1182/blood.v91.8.2977.2977_2977_2984 · Cited by 290
Ichimura, K., Bondesson, M., Goike, H., Schmidt, E., Moshref, A., & Collins, V. P. (2000) · PubMed · Cited by 283
Hebert, J., Cayuela, J., Berkeley, J., & Sigaux, F. (1994) · Blood · doi:10.1182/blood.v84.12.4038.bloodjournal84124038 · Cited by 281
p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
Carnero, A., Hudson, J. D., Price, C. M., & Beach, D. H. (2000) · Nature Cell Biology · doi:10.1038/35004020 · Cited by 279
Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex
Weber, J. D., Kuo, M.-L., Bothner, B., DiGiammarino, E. L., Kriwacki, R. W., Roussel, M. F., & Sherr, C. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2517-2528.2000 · Cited by 275
Brenner, A. J., Stampfer, M. R., & Aldaz, C. M. (1998) · Oncogene · doi:10.1038/sj.onc.1201919 · Cited by 272
(1996) · PubMed · Cited by 242
Mutation and altered expression of p16^ in human cancer
Okamoto, A. (1994) · Proceedings of the National Academy of Sciences · Cited by 234
Quelle, D. E., Cheng, M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 220
Brotherton, D. H., Dhanaraj, V., Wick, S., Brizuela, L., Domaille, P. J., Volyanik, E., Xu, X., Parisini, E., Smith, B. O., Archer, S. J., et al. (1998) · Nature · doi:10.1038/26164 · Cited by 210
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)90160-4 · Cited by 205
FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 200
Wong, I. H. N., Ng, M. H. L., Huang, D. P., & Lee, J. C. K. (2000) · Blood · doi:10.1182/blood.v95.6.1942 · Cited by 199
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.
Wong, D. J., Barrett, M. T., Stöger, R. J., Emond, M. J., & Reid, B. J. (1997) · PubMed · Cited by 192
Deletion of the p16 and p15 Genes in Human Bladder Tumors
Orlow, I., Lacombe, L., Hannon, G. J., Serrano, M., Pellicer, I., Dalbagni, G., Reuter, V. E., Zhang, Z.-F., Beach, D., & Cordon-Cardo, C. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1524 · Cited by 184
Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Shapiro, G. I., Park, J. E., Edwards, C. D., Mao, L., Merlo, A. U., Sidransky, D., Ewen, M. E., & Rollins, B. J. (1995) · PubMed · Cited by 181
Self-citationXing, E. P., Nie, Y., Song, Y., Yang, G., Cai, Y., Wang, L., & Yang, C. S. (1999) · PubMed · Cited by 180
(1996) · PubMed · Cited by 180
p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
Williamson, M. P., Elder, P. A., Shaw, M. E., Devlin, J., & Knowles, M. A. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.9.1569 · Cited by 179
Jarrard, D. F., Bova, G. S., Ewing, C. M., Pin, S. S., Nguyen, S. H., Baylin, S. B., Cairns, P., Sidransky, D., Herman, J. G., & Isaacs, W. B. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199706)19:2<90::aid-gcc4>3.0.co;2-v · Cited by 175
Self-citationTaniguchi, K., Kohsaka, H., Inoue, N., Terada, Y., Ito, H., Hirokawa, K., & Miyasaka, N. (1999) · Nature Medicine · doi:10.1038/10480 · Cited by 168
Frequent Methylation Silencing of p15INK4b(MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas
Baur, A. S., Shaw, P., Burri, N., Delacrétaz, F., Bosman, F. T., & Chaubert, P. (1999) · Blood · doi:10.1182/blood.v94.5.1773 · Cited by 165
Ohta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D., Mastrangelo, M. J., Singh, A. D., Shields, J. A., Shields, C. L., & Croce, C. M. (1994) · PubMed · Cited by 165
Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias
Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M., Tanaka, T., Mitani, K., & Yazaki, Y. (1994) · Blood · doi:10.1182/blood.v84.8.2431.2431 · Cited by 161
Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia
Hatta, Y., Hirama, T., Miller, C., Yamada, Y., Tomonaga, M., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v85.10.2699.bloodjournal85102699 · Cited by 161
Genetic Progression and Divergence in Pancreatic Carcinoma
Yamano, M., Fujii, H., Takagaki, T., Kadowaki, N., Watanabe, H., & Shirai, T. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65083-3 · Cited by 160
Jarrard, D. F., Sarkar, S., Shi, Y., Yeager, T. R., Magrane, G., Kinoshita, H., Nassif, N., Meisner, L. F., Newton, M. A., Waldman, F. M., et al. (1999) · PubMed · Cited by 157
p16INK4a can initiate an autonomous senescence program
Dai, C. Y., & Enders, G. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203438 · Cited by 154
Association of K-ras mutations with p16 methylation in human colon cancer
Guan, R. J., Fu, Y., Holt, P. R., & Pardee, A. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70009-0 · Cited by 151
Overcoming cellular senescence in human cancer pathogenesisPreprint
Yeager, T. R., DeVries, S., Jarrard, D. F., Kao, C. H., Nakada, S. Y., Moon, T. D., Bruskewitz, R. C., Stadler, W. M., Meisner, L. F., Gilchrist, K. W., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.163 · Cited by 151
Zhang, S., Ramsay, E. S., & Mock, B. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2429 · Cited by 147
Requirements for Cell Cycle Arrest by p16INK4a
Bruce, J. L., Hurford, R. K., Classon, M., Koh, J., & Dyson, N. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00072-1 · Cited by 146
Batova, A., Diccianni, M. B., Yu, J., Nobori, T., Link, M. P., Pullen, J., & Yu, A. L.-T. (1997) · PubMed · Cited by 146
Tumour-suppressor genes: evolving definitions in the genomic age
Haber, D. A., & Harlow, E. (1997) · Nature Genetics · doi:10.1038/ng0897-320 · Cited by 141
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores, J. F., Walker, G. J., Glendening, J. M., Haluska, F. G., Castresana, J. S., Rubio, M., Pastorfide, G. C., Boyer, L. A., Kao, W. H., Bulyk, M. L., et al. (1996) · PubMed · Cited by 137
Deletions of the INK4A Gene in Superficial Bladder Tumors
Orlow, I., LaRue, H., Osman, I., Lacombe, L., Moore, L., Rabbani, F., Meyer, F., Fradet, Y., & Cordon‐Cardo, C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65105-x · Cited by 134
Harada, H., Nakagawa, K., Iwata, S., Saito, M., Kumon, Y., Sakaki, S., Sato, K., & Hamada, K. (1999) · PubMed · Cited by 133
p16 gene homozygous deletions in acute lymphoblastic leukemia
Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Laï, J., Bauters, F., Wattel, E., & Fenaux, P. (1995) · Blood · doi:10.1182/blood.v85.3.657.bloodjournal853657 · Cited by 133
Induction of senescence in human malignant glioma cells by p16INK4A
Uhrbom, L., Nistér, M., & Westermark, B. (1997) · Oncogene · doi:10.1038/sj.onc.1201227 · Cited by 132
Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia
Guo, S.-X., Taki, T., Ohnishi, H., Piao, H., Tabuchi, K., Bessho, F., Hanada, R., Yanagisawa, M., & Hayashi, Y. (2000) · Leukemia Research · doi:10.1016/s0145-2126(99)00158-7 · Cited by 130
Sánchez‐Céspedes, M., Reed, A. L., Buta, M. R., Li, W., Westra, W. H., Herman, J. G., Yang, S. C., Jen, J., & Sidransky, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203003 · Cited by 130
Self-citationMethylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.
El‐Naggar, A. K., Lai, S., Clayman, G. L., Lee, J. K., Luna, M. A., Goepfert, H., & Batsakis, J. G. (1997) · Europe PMC (PubMed Central) · Cited by 129
Gonzalgo, M. L., Bender, C. M., You, E., Glendening, J. M., Flores, J. F., Walker, G. J., Hayward, N. K., Jones, P. A., & Fountain, J. W. (1997) · PubMed · Cited by 128
Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence
Erickson, S., Sangfelt, O., Heyman, M. M., Castro, J., Einhorn, S., & Grandér, D. (1998) · Oncogene · doi:10.1038/sj.onc.1201965 · Cited by 125
Guo, W., Lonardo, F., Ueda, T., Kim, T. K., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2<199::aid-ijc7>3.0.co;2-4 · Cited by 125
Vogt, M., Haggblom, C., Yeargin, J., Christiansen-Weber, T. A., & Haas, M. (1998) · PubMed · Cited by 124
Wiencke, J. K., Zheng, S., Lafuente, A., et al. (1999) · PubMed · Cited by 123
Heinmöller, E., Dietmaier, W., Zirngibl, H., Heinmöller, P., Scaringe, W., Jauch, K.-W., Hofstädter, F., & Rüschoff, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64520-8 · Cited by 121
Villuendas, R., Sánchez‐Beato, M., Martínez, J. C., Sáez, A. I., Martínez–Delgado, B., García, J. F., Mateo, M. S., Sánchez‐Verde, L., Benitez, J. J., Martínez, P., et al. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65630-1 · Cited by 121
Molecular Genetic Correlates of p16, cdk4, and pRb Immunohistochemistry in Glioblastomas
Burns, K. L., Ueki, K., Jhung, S., Koh, J., & Louis, D. N. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199802000-00003 · Cited by 120
Hui, R., Macmillan, R. D., Kenny, F. S., Musgrove, E. A., Blamey, R. W., Nicholson, R. I., Robertson, J. F. R., & Sutherland, R. L. (2000) · PubMed · Cited by 120
Walker, D., Duan, W., Popovic, E. A., Kaye, A. H., Tomlinson, F. H., & Lavin, M. F. (1995) · PubMed · Cited by 119
p16INK4a and the control of cellular proliferative life span
Huschtscha, L. I., & Reddel, R. R. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.921 · Cited by 118
Hayashi, N., Sugimoto, Y., Tsuchiya, E., Ogawa, M., & Nakamura, Y. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2090 · Cited by 117
Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., et al. (1996) · Blood · doi:10.1182/blood.v87.12.4949.bloodjournal87124949 · Cited by 116
Nosaka, K., Maeda, M., Tamiya, S., Sakai, T., Mitsuya, H., & Matsuoka, M. (2000) · PubMed · Cited by 116
A Novel Function for the Tumor Suppressor p16INK4a
Plath, T., Detjen, K. M., Welzel, M., von Marschall, Z., Murphy, D. B., Schirner, M., Wiedenmann, B., & Rosewicz, S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.6.1467 · Cited by 114
Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Frye, C., Eeles, R. A., Orlow, I., Lacombe, L., Ponce-Castañeda, V., LIANES, P., & Latres, E. (1995) · Europe PMC (PubMed Central) · Cited by 113
Fåhræus, R., & Lane, D. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2106 · Cited by 113
Xing, E. P., Nie, Y., Wang, L., Yang, G.-Y., & Yang, C. S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.1.77 · Cited by 113
Prognostic impact of INK4A deletion in Ewing sarcoma
Guo, W., Antonescu, C. R., de Álava, E., Leung, D. H. Y., Huvos, A. G., Meyers, P. A., Healey, J. H., & Ladanyi, M. (2000) · Cancer · Cited by 111
CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB Alterations
Nielsen, G. P., Burns, K. L., Rosenberg, A. E., & Louis, D. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65556-3 · Cited by 111
Simpson, D. J. W., Bicknell, J., McNicol, A. M., Clayton, R. N., & Farrell, W. E. (1999) · PubMed · Cited by 110
The MTS1 gene is frequently mutated in primary human esophageal tumors.
Zhou, X., Tarmin, L., Yin, J., Jiang, H. Y., Suzuki, H., Rhyu, M. G., Abraham, J. M., & Meltzer, S. J. (1994) · PubMed · Cited by 110
Geradts, J., Fong, K. M., Zimmerman, P. V., Maynard, R. D., & Minna, J. D. (1999) · PubMed · Cited by 107
Genomic Alterations of the p19ARF Encoding Exons in T-Cell Acute Lymphoblastic Leukemia
Gardie, B., Cayuela, J., Martini, S., & Sigaux, F. (1998) · Blood · doi:10.1182/blood.v91.3.1016 · Cited by 106
Goldstein, A. M., Dracopoli, N. C., Engelstein, M., Fraser, M. C., Clark, W. H., & Tucker, M. A. (1994) · PubMed Central · Cited by 105
Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., & Shimazaki, C. (1995) · Blood · doi:10.1182/blood.v86.4.1548.bloodjournal8641548 · Cited by 104
Fizzotti, M., Cimino, G. G., Pisegna, S., Alimena, G., Quartarone, C., Mandelli, F., Pelicci, P. G., & Coco, F. L. (1995) · Blood · doi:10.1182/blood.v85.10.2685.bloodjournal85102685 · Cited by 104
Alterations of the p15, p16, and p18 genes in osteosarcoma
Miller, C. W., Aslo, A., Campbell, M. J., Kawamata, N., Lampkin, B. C., & Koeffler, H. P. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00216-2 · Cited by 103
Deletions and rearrangement of CDKN2 in lymphoid malignancy
Stranks, G., Height, S., Mitchell, P. L. R., Jadayel, D. M., Ma, Y., Lord, C., Clutterbuck, R. D., Treleaven, J., Powles, R. L., & Nacheva, E. P. (1995) · Blood · doi:10.1182/blood.v85.4.893.bloodjournal854893 · Cited by 102
Frequent loss of the P16INK4a gene product in human pituitary tumors.
Woloschak, M., Yu, A., Xiao, J., & Post, K. D. (1996) · PubMed · Cited by 102
Mælandsmo, G. M., Berner, J. M., Flørenes, V. A., Forus, A., Hovig, E. J., Fodstad, Ø., & Myklebost, O. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.344 · Cited by 102
Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.
Holland, E. A., Beaton, S. C., Becker, T. M., Grulet, O., Peters, B. A., Rizos, H., Kefford, R. F., & Mann, G. J. (1995) · PubMed · Cited by 101
Alteration of pRb/p16/cdk4 regulation in human osteosarcoma
Benassi, M. S., Molendini, L., Gamberi, G., Ragazzini, P., Sollazzo, M. R., Merli, M., Asp, J., Magagnoli, G., Balladelli, A., Bertoni, F., et al. (1999) · International Journal of Cancer · Cited by 99
Møller, M. B., Ino, Y., Gerdes, A., Skøjdt, K., Louis, D., & Pedersen, N. (1999) · Leukemia · doi:10.1038/sj.leu.2401315 · Cited by 96
Cayuela, J., Madani, A., Sanhes, L., Stern, M., & Sigaux, F. (1996) · Blood · doi:10.1182/blood.v87.6.2180.bloodjournal8762180 · Cited by 94
Maesawa, C., Tamura, G., Nishizuka, S., Ogasawara, S., Ishida, K., Terashima, M., Sakata, K., Sato, N., Saito, K., & Satodate, R. (1996) · PubMed · Cited by 93
Munro, J., Stott, F. J., Vousden, K. H., Peters, G., & Parkinson, E. K. (1999) · PubMed · Cited by 93
Klangby, U., Okan, İ., Magnússon, K. P., Wendland, M., Lind, P., & Wiman, K. G. (1998) · Blood · doi:10.1182/blood.v91.5.1680 · Cited by 93
Mutation rate of the CDKN2 gene in malignant gliomas.
Giani, C., & Finocchiaro, G. (1994) · PubMed · Cited by 92
Brenner, A. J., & Aldaz, C. M. (1995) · PubMed · Cited by 92
Schultz, D., Vanderveer, L., Buetow, K. H., Boente, M. P., Ozols, R. F., Hamilton, T. C., & Godwin, A. K. (1995) · PubMed · Cited by 92
MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p
Ueki, K., Rubio, M., Ramesh, V., Correa, K. M., Rutter, J. L., von Deimling, A., Buckler, A., Gusella, J. F., & Louis, D. N. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.10.1841 · Cited by 92
Deletion mapping of chromosome region 9p21-p22 surrounding theCDKN2 locus in melanoma
Ohta, M., Berd, D., Shimizu, M., Nagai, H., Cotticelli, M., Mastrangelo, M. J., Shields, J. A., Shields, C. L., Croce, C. M., & Huebner, K. (1996) · International Journal of Cancer · Cited by 90
Huang, L., Goodrow, T. L., Zhang, S. Y., Klein-Szanto, A. J., Chang, H., & Ruggeri, B. (1996) · PubMed · Cited by 86
p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
Rocco, J. W., Li, D., Liggett, W. H., Duan, L., Saunders, J. K., Sidransky, D., & O'Malley, B. W. (1998) · PubMed · Cited by 86
Self-citationAnalysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds
Flores, J. F., Pollock, P. M., Walker, G. J., Glendening, J. M., Lin, A. H.-T., Palmer, J. M., Walters, M. K., Hayward, N. K., & Fountain, J. W. (1997) · Oncogene · doi:10.1038/sj.onc.1201470 · Cited by 84
Ohnishi, H., Kawamura, M., Ida, K., Sheng, X., Hanada, R., Nobori, T., Yamamori, S., & Hayashi, Y. (1995) · Blood · doi:10.1182/blood.v86.4.1269.bloodjournal8641269 · Cited by 84
Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas
Bartsch, D. K., Shevlin, D. W., Tung, W. S., Kisker, O., Wells, S. A., & Goodfellow, P. J. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870140306 · Cited by 80
Chemoprevention in hereditary colorectal cancer syndromes
Hawk, E. T., Lubet, R., & Limburg, P. J. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11+<2464::aid-cncr3>3.0.co;2-f · Cited by 80
High prevalence of p16 genetic alterations in head and neck tumours
Miracca, E. C., Kowalski, L. P., & Nagai, M. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690747 · Cited by 78
Expression of p16 induces transcriptional downregulation of the RB gene
Fang, X., Jin, X., Xu, H., Liu, L., Peng, H.-Q., Hogg, D., Roth, J. A., Yu, Y., Xu, F., Bast, R. C., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201525 · Cited by 77
Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma
Corson, J. M. (1995) · Lung Cancer · doi:10.1016/0169-5002(96)84216-4 · Cited by 76
Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas
Newcomb, E. W., Alonso, M., Sung, T., & Miller, D. C. (2000) · Human Pathology · doi:10.1016/s0046-8177(00)80207-5 · Cited by 75
CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma Kindreds
Fargnoli, M. C., Chimenti, S., Peris, K., Keller, G., Soyer, H. P., Pozzo, V. D., & Höfler, H. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00412.x · Cited by 73
MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
Moulton, T. A., Samara, G., Chung, W., Yuan, L., Desai, R. D., Sisti, M. B., Bruce, J., & Tycko, B. (1995) · PubMed Central · Cited by 72
Schmidt, E., Ichimura, K., Messerle, K. R., Goike, H., & Collins, V. P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.2 · Cited by 72
p16/CDKN2 andCDK4 gene mutations in sporadic melanoma development and progression
Piccinin, S., Doglioni, C., Maestro, R., Vukosavijevic, T., Gasparotto, D., D'Orazi, C., & Boiocchi, M. (1997) · International Journal of Cancer · Cited by 72
Yang, X., He, Z., Xin, B., & Cao, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203515 · Cited by 71
p16INK4A and p15INK4B gene deletions in primary leukemias
Haidar, M., Cao, X., Manshouri, T., Chan, L. L., Glassman, A. B., Kantarjian, H., Keating, M. J., Beran, M., & Albitar, M. X. (1995) · Blood · doi:10.1182/blood.v86.1.311.bloodjournal861311 · Cited by 71
Heinzel, P. A., Balaram, P., & Bernard, H. (1996) · International Journal of Cancer · Cited by 70
Iolascon, A., Faienza, M. F., Coppola, B., Rosolen, A., Basso, G., Ragione, F. D., & Schettini, F. (1996) · Genes Chromosomes and Cancer · Cited by 69
El‐Naggar, A. K., Lai, S., Clayman, G. L., Zhou, J.-H., Tucker, S., Myers, J., Luna, M. A., & Benedict, W. F. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90217-4 · Cited by 69
Ritchie, C. K., Thomas, K. G., Andrews, L. R., Tindall, D. J., & Fitzpatrick, L. A. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970215)30:3<188::aid-pros7>3.0.co;2-i · Cited by 68
Loughran, Ö., Clark, L., Bond, J., Baker, A. H., Berry, I. J., Edington, K. G., Ly, I.-S., Simmons, R. L., Haw, R., Black, D. M., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201028 · Cited by 67
Møller, M. B., Kania, P., Ino, Y., Gerdes, A., Nielsen, O., Louis, D., Skjødt, K., & Pedersen, N. (2000) · Leukemia · doi:10.1038/sj.leu.2401761 · Cited by 64
Association of extended in vitro proliferative potential with loss of p16INK4 expression.
Noble, J. R., Rogan, E. M., Neumann, A. A., MacLean, K. H., Bryan, T. M., & Reddel, R. R. (1996) · PubMed · Cited by 64
Dreyling, M. H., Roulston, D., Bohlander, S. K., Vardiman, J. W., & Olopade, O. I. (1998) · Genes Chromosomes and Cancer · Cited by 64
Genetic heterogeneity in familial malignant melanoma
MacGeoch, C., Newton‐Bishop, J., Batallle, V., Bishop, D. T., Frischauf, A.-M., Melonl, R., Cuzlck, J., Plnney, E., & Spurr, N. K. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2195 · Cited by 63
p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
Fujimoto, A., Morita, R., Hatta, N., Takehara, K., & Takata, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202803 · Cited by 61
Dreyling, M. H., Bohlander, S. K., Adeyanju, M., & Olopade, O. I. (1995) · PubMed · Cited by 60
Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas
Kumar, R., Rozell, B. L., Louhelainen, J., & Hemminki, K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980119)75:2<193::aid-ijc5>3.0.co;2-p · Cited by 59
Gombart, A., Roberta Morosetti, A., Cw, M., Said, J. W., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v86.4.1534.bloodjournal8641534 · Cited by 59
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
Brenner, A. J., Paladugu, A. V., Wang, H., Olopade, O. I., Dreyling, M. H., & Aldaz, C. M. (1996) · PubMed · Cited by 58
Infrequent Mutation of p16INK4 in Sporadic Melanoma
Healy, E., Sikkink, S. K., & Rees, J. L. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12363118 · Cited by 58
Florl, A. R., Franke, K. H., Niederacher, D., Gerharz, C., Seifert, H., & Schulz, W. A. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780161 · Cited by 57
González, M., Mateos, M., García‐Sánz, R., Balanzategui, A., López‐Pérez, R., Chillón, C., González, D., Alaejos, I., & Miguel, J. F. S. (2000) · Leukemia · doi:10.1038/sj.leu.2401617 · Cited by 57
Coleman, A. B., Fountain, J. W., Nobori, T., Olopade, O. I., Robertson, G. P., Housman, D. E., & LUGO, T. G. (1994) · PubMed · Cited by 56
p15ink4B and p16ink4 gene inactivation in acute lymphocytic leukemia
Rasool, O., Heyman, M. M., Brandter, L., Liu, Y., Grandér, D., Söderhäll, S., & Einhorn, S. (1995) · Blood · doi:10.1182/blood.v85.12.3431.bloodjournal85123431 · Cited by 56
Balázs, M., Carroll, P. R., KERSCHMANN, R. L., Sauter, G., & Waldman, F. M. (1997) · Genes Chromosomes and Cancer · Cited by 55
Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas
Tsuzuki, T., Tsunoda, S., Sakaki, T., Konishi, N., Hiasa, Y., & Nakamura, M. (1996) · Cancer · Cited by 51
Li, Y., Hoang‐Xuan, K., Delattre, J., Poisson, M., Thomas, G. D., & Hamelin, R. (1995) · PubMed · Cited by 51
Migeon, B. R. (1990) · Genetics Research · doi:10.1017/s0016672300035151 · Cited by 50
Dreyling, M. H., Roulston, D., Bohlander, S. K., Vardiman, J. W., & Olopade, O. I. (1998) · Genes Chromosomes and Cancer · Cited by 50
Alteration of p16 and p15 genes in common epithelial ovarian tumors
Fujita, M., Enomoto, T., Haba, T., Nakashima, R., Sasaki, M., Yoshino, K., Wada, H., Buzard, G. S., Matsuzaki, N., Wakasa, K., et al. (1997) · International Journal of Cancer · Cited by 48
p16 mutations/deletions are not frequent events in prostate cancer
Tamimi, Y., Bringuier, P., Smit, F. P., van Bokhoven, A., Debruyne, F. M. J., & Schalken, J. A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.325 · Cited by 47
Mutations of the p16 gene in gliomas.
Kyritsis, A. P., Zhang, B., Zhang, W., Xiao, M., Takeshima, H., Bondy, M. L., Cunningham, J. E., Levin, V. A., & Bruner, J. (1996) · PubMed · Cited by 47
Mutational analysis of the CDKN2 (MTS1/p16ink4A) gene in primary B-cell lymphomas
Uchida, T., Watanabe, T., Kinoshita, T., Murate, T., Saito, H., & Hotta, T. (1995) · Blood · doi:10.1182/blood.v86.7.2724.2724 · Cited by 46
Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas
Esteve, A., Martel‐Planche, G., Sylla, B. S., Hollstein, M., Hainaut, P. L., & Montesano, R. (1996) · International Journal of Cancer · Cited by 45
Analysis of the p16 tumor suppressor gene in early‐stage prostate cancer
Gu, K., Mes‐Masson, A., Gauthier, J. B., & Saad, F. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199803)21:3<164::aid-mc3>3.3.co;2-c · Cited by 45
Morisaki, H., Ando, A., Nagata, Y., Pereira‐Smith, O. M., Smith, J. R., Ikeda, K., & Nakanishi, M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4698 · Cited by 44
Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
Chi, S. G., White, R. D., Muenzer, J. T., & Gumerlock, P. H. (1997) · PubMed · Cited by 44
Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients
Patiño‐García, A., & Sierrasesúmaga, L. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00397-4 · Cited by 43
p16andp15Alterations in Primary Gynecologic Malignancy
Wong, Y. F., Chung, T. K. H., Cheung, T. H., Nobori, T., Yim, S. F., Lai, K. W. H., Yu, A. L.-T., Diccianni, M. B., Li, T. Z., & Chang, A. M. Z. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4669 · Cited by 42
Iolascon, A., Faienza, M. F., Coppola, B., Ragione, F. D., Schettini, F., & Biondi, A. (1996) · PubMed · Cited by 42
p16 (INK4a, MTS‐1) gene polymorphism and methylation status in human pituitary tumours
Jaffrain‐Rea, M., Ferretti, E., Toniato, E., Cannita, Santoro, A., Stefano, M. D., Ricevuto, E., Maroder, Tamburrano, Cantore, et al. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00774.x · Cited by 39
Ichikawa, Y., Yoshida, S., Koyama, Y., Hirai, M., Ishikawa, T., Nishida, M., Tsunoda, H., Kubo, T., Miwa, M., & Uchida, K. (1996) · International Journal of Cancer · Cited by 39
Analysis of p16 gene deletion and point mutation in breast carcinoma
Quesnel, B., Fenaux, P., Philippe, N., Fournier, J., Bonneterre, J. M., Preudhomme, C., & Peyrat, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.337 · Cited by 34
Contribution of Chromosome 9p21‐22 Deletion to the Progression of Human Renal Cell Carcinoma
Kinoshita, H., Yamada, H., Ogawa, O., Kakehi, Y., Osaka, M., Nakamura, E., Mishina, M., Habuchi, T., Takahashi, R., Sugiyama, T., et al. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03087.x · Cited by 34
Absence of p16/MTS1 gene mutations in human prostate cancer
Chen, W., Weghorst, C. M., Sabourin, C. L. K., Wang, Y., Wang, D., Bostwick, D. G., & Stoner, G. D. (1996) · Carcinogenesis · doi:10.1093/carcin/17.12.2603 · Cited by 34
Cited by
Argiris, A., Karamouzis, M. V., Raben, D., & Ferris, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60728-x · Cited by 2,224
Shih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046
Viglietto, G., Motti, M. L., Bruni, P., Melillo, R. M., D'Alessio, A., Califano, D., Vinci, F., Chiappetta, G., Tsichlis, P., Bellacosa, A., et al. (2002) · Nature Medicine · doi:10.1038/nm762 · Cited by 701
Metadata
- Authors
- Rocco, J. W., & Sidransky, D.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 264
- Issue
- 1
- Pages
- 42-55
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W2105428856
- Cited by
- 470
- References
- 224
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.